Sage Journals: Discover world-class research

Open access

Review article

First published 2022-06

Tislelizumab: A Modified Anti-tumor Programmed Death Receptor 1 Antibody

Lin Zhang, Zhihua Geng, Bo Hao [...]

Cancer Control

Open access

Research article

First published 2018

Diverse cutaneous adverse eruptions caused by anti-programmed cell death-1 (PD-1) and anti-programmed cell death ligand-1 (PD-L1) immunotherapies: clinical features and management

John Shen, Jason Chang, Melody Mendenhall [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2017-03

Novel Treatment of Melanoma: Combined Parasite-Derived Peptide GK-1 and Anti-Programmed Death Ligand 1 Therapy

Jesus Vera-Aguilera, Armando Perez-Torres, Diego Beltran [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2024-02

Establishment of Anti-Dog Programmed Cell Death Ligand 1 Monoclonal Antibodies for Immunohistochemistry

Tsunenori Ouchida, Hiroyuki Suzuki, Tomohiro Tanaka [...]

Monoclonal Antibodies in Immunodiagnosis & Immunotherapy

Open access

Research article

First published 2024-7

Efficacy and safety of anti-programmed death-1 antibody-based combination therapy in advanced or metastatic gastric or gastroesophageal junction cancer in Chinese patients: A real-world study

Yifan Gao, Haoqian Li, Lei Qiu [...]

Science Progress

Open access

Research article

First published 2021

Efficacy and Safety of Anti-Programmed Cell Death Protein-1 Immunotherapy for Advanced Hepatocellular Carcinoma With Pulmonary Metastases: A Single-Center,Retrospective Study

Mei Zhao, Yiruo Zhang, Hua Wang [...]

Technology in Cancer Research & Treatment

Open access

Research article

First published 2020

Surrogate endpoints for overall survival in anti-programmed death-1 and anti-programmed death ligand 1 trials of advanced melanoma

Run-Cong Nie, Shu-Qiang Yuan, Yun Wang [...]

Therapeutic Advances in Medical Oncology

Retricted access

Case report

First published 2018-6

Tubulitis in a patient treated with nivolumab: Case report and literature review

Viral Vakil, Mark Birkenbach, Katti Woerner [...]

Journal of Onco-Nephrology

Retricted access

Research article

First published 2022-6

A case of atezolizumab-associated tubulointerstitial nephritis

Elena V Zakharova, Tatyana A Makarova, Olga A Vorobyeva

Journal of Onco-Nephrology

Open access

Research article

First published 2025

Anti-programmed death-1 inhibitors and nimotuzumab in combination with induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis

Ya-Ni Zhang, Yu-Pei Chen, Pu-Yun OuYang [...]

Therapeutic Advances in Medical Oncology

Search results